Today’s interview is with Katherine Eban, an investigative journalist who uncovered the widespread fraud that goes on overseas in the manufacturing of U.S. generic drugs.
With the outbreak of the deadly coronavirus, which originated in China but is now spreading across the globe and United States, today’s interview is especially timely. Katherine’s recent book, “Bottle of Lies,” reveals that nearly 80 percent of the active ingredients of all brand-name and generic drugs as well as almost all of our antibiotics in the U.S. are made outside of the country, mostly in China and India. Today’s interview highlights the dangers Americans face in outsourcing the quality and safety of its brand-name and generic drugs to overseas manufacturers.
Katherine is an investigative journalist who has written award-winning stories that range from pharmaceutical counterfeiting to gun trafficking to even coercive interrogations by the CIA. Her first book, “Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply,” was named one of the Best Books of 2005 by Kirkus Reviews.
“Bottle of Lies: The Inside Story of the Generic Drug Boom” is a New York Times bestseller that came out in 2019 and was named one of the top 100 notable books of 2019 by the Times.
Show notes:
[00:03:16] Dawn opens the interview mentioning Katherine’s appearance on Peter Attia’s podcast.
[00:04:30] Ken asks how Katherine how she ended up living just three subway stops from where she grew up in Brooklyn.
[00:05:01] Katherine talks about how despite her talent and interest in writing, she at one point joined the circus in high school and considered going to clown school after she graduated.
[00:06:02] Dawn asks how Katherine ended up in Rhode Island to attend Brown University instead of going to Florida to attend the Ringling Brothers Clown College.
[00:06:47] Katherine talks about her time at Brown University editing the school’s literary magazine.
[00:07:24] Ken Asks about Katherine’s time at Oxford University as a Rhodes scholar.
[00:08:37] Dawn asks how Katherine, a woman who holds a Master’s degree in 17th Century English Epic Civil War Poetry, became a journalist.
[00:10:23] Dawn asks about Katherine’s first big story, which also happened to be her first story.
[00:11:49] Dawn asks Catherine long she worked at the New York Times.
[00:13:07] Katherine explains how she came to write her first book, “Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply.”
[00:14:56] Dawn mentions that after the publishing of “Dangerous Doses,” Katherine spent a decade investigating the generic-drug industry, an investigation sparked by a phone call from a colleague who asked for her help.
[00:16:17] Ken asks about the difference between a generic and brand-name drug, and what is involved in the process of reverse-engineering a drug.
[00:17:43] Dawn asks about the series of interviews Katherine conducted with patients sharing their experiences with generic drugs, which led to a story she wrote for “Self” magazine in 2009.
[00:20:15] Ken mentions that in the “Self” magazine article, Katherine wrote about Dr. Kesselheim, an instructor at Harvard Medical school who reviewed data from 47 clinical studies. He found no evidence that patients on brand-name cardiovascular drugs had outcomes superior to those on generics. Given this study is now 10 years old, Ken asks if anyone has revisited this analysis.
[00:21:25] Katherine tells the story of her anonymous informant that contacted her about a month after the “Self” magazine article, who went by the pseudonym “4 Dollar Refill.”
[00:22:38] Dawn mentions that over the following five years, Katherine wrote a series of articles about generic-drug quality, which culminated in a 10,000-word article titled “Dirty Medicine” published in Fortune Magazine in 2013.
Episode 104: Katherine Eban talks about the dangers associated with relying on generic drugs manufactured overseas | STEM-Talk podcast - Listen or read transcript on Metacast
